IVD Trends and Market Update, 2022 - Research and Markets

What's Driving Growth in the IVD Market in Q3 and the last half of 2022?
What Major Trends are Affecting the Market in Q3 and the last half of 2022?
How Has COVID-19 Impacted and Continued to Impact the Market in Q3 and the last half of 2022?
What Product Trends and New Developments Will Shape the IVD Market in the last half of 2022?

Diagnostic test products have never been more important. This report is an update of the market for in vitro diagnostics products from the analysts to reflect the latest information as of Q3 2022 with a publication date of November 2022.

The demand for testing and movement of current and new technologies has continued to demonstrate gains in most areas of the IVD market. New products, changes in global health spending, regulatory changes in major markets, and disease trends are among the factors that produce a constantly evolving market picture. There are some growing segments in the market that have attracted industry attention. Among these are next-generation sequencing (NGS), personalized medicine, and mass spectrometry. Immunochemistry, point-of-care (POC) testing, and molecular diagnostics are also segments of great market interest, anticipated to be a core part of the future of IVD. The IVD market remains dynamic, demonstrating constant innovations.

The analyst continues to be diligent in outlining the IVD market and its rapidly changing landscape. The analyst has been and continues to be superior in accessing the market due to the extensive experience of its authors and commitment by the company to present the most accurate data available.

Chapter 1: Worldwide IVD Market - November 2022 Update

IVD Market Demand and Growth
Figure 1-1: Quarter-by-Quarter Segment Performance Commentary, 2022
Table 1-1: Global In Vitro Diagnostic Sales by Product Market, 2022 ($ million) (Clinical Chemistry; Immunoassays - non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab; Hematology - Core Lab; Microbiology (ID/AST); Microbiology (molecular); Microbiology - Mass Spectrometry; Coagulation (PT/INR); Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry; Other IVD)
Figure 1-2: IVD Segment Performance, Q1 2022 - Q4 2022e ($MN)
Figure 1-3: IVD Segment Performance, Total Market Value, 2022 ($MN)
COVID-19 Diagnostic Markets
Table 1-2: COVID-19 Product Sales - Immunoassay (Antigen, Serology), Molecular, Rapid - 2022 ($ millions)
Effect of COVID-19 on Market Segments
Table 1-3: IVD Market excluding and with COVID-19, 2022
Figure 1-4: IVD Market Distribution by Segment, 2022
Figure 1-5: IVD Market by COVID-19 and non-COVID markets, Quarterly Performance, 2022
Table 1-4: Global In Vitro Diagnostic Market - YoY Growth 2021-2022
Figure 1-6: Global In Vitro Diagnostic Market - YoY Growth 2021-2022

Chapter 2: Product Trends and New Developments

Selected New - Q3 2022 - Core IVD Product Launches, Developments and Trends
Clinical Chemistry
Flow Cytometry
Immunoassay
Mass Spectrometry
Molecular
Personalized Medicine
POC
Sequencing
Selected COVID-19 Developments - Q3 2022
Figure 2-1: COVID-19 Test Market by Type, Q1-Q3 2022 - COVID-19 Testing Wanes
Antigen/Antibody
Molecular

Chapter 3: Top IVD Market Participant Results

Selected Competitive Leader Updates
Figure 3-1: IVD Segment Growth by Leading Competitors, Change in Sales 2021-2022
Figure 3-2: Changes in Market Distribution for IVD Sales, 2019 - 2022 - Roche and Abbott Battle for #1 Spot
Figure 3-3: Comparison of Total Diagnostic Sales for Abbott vs Roche 2020-2022 (in millions $)
Q3 M&A Activity
Table 3-1: IVD-Relevant M&A Activity, 2022
Figure 3-4: Count of IVD Industry M&A Deals by Month, 2022
Abbott Laboratories
Table 3-2: Abbott Corporate Summary
Becton Dickinson and Co
Table 3-3: Becton Dickinson Corporate Summary
bioMérieux SA
Table 3-4: bioMérieux Corporate Summary
Danaher Corporation
Table 3-5: Danaher Corporation Summary
Hologic, Inc.
Table 3-6: Hologic Corporate Summary
QuidelOrtho Corporation
Table 3-7: QuidelOrtho Corporate Summary
Roche Diagnostic
Table 3-8: Roche Diagnostic Corporate Summary
Siemens Healthineers
Table 3-9: Siemens Healthineers Corporate Summary
Sysmex Corporation
Table 3-10: Sysmex Corporate Summary
Thermo Fisher Scientific
Table 3-11: Thermo Fisher Scientific Corporate Summary

Chapter 4: New Opportunities

Artificial Intelligence Future Trends
At-Home Testing
Microfluidics in IVD
Telehealth

Companies Mentioned

Abbott Laboratories
Becton Dickinson and Co
bioMérieux SA
Danaher Corporation
Hologic, Inc.
QuidelOrtho Corporation
Roche Diagnostic
Siemens Healthineers
Sysmex Corporation
Thermo Fisher Scientific

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - Lifetime	The product can be accessed through a secure website. Username and password will be sent via email. The access never expires.	This is a single user license, allowing one user access to the product.	€4801EUR$5,000USD£4,008GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€7202EUR$7,500USD£6,012GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€9603EUR$10,000USD£8,016GBP

Table of Contents

Companies Mentioned

Related Topics

Related Reports

In Vitro Diagnostic (IVD) Trends and Market Update: March 2024

In Vitro Diagnostics (IVD) Analyzers: Global Market

In Vitro Diagnostics Market by Product & Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Specimen (Blood, Saliva), Test Type, Application (Oncology, Autoimmune, CVD, Infectious Diseases) - Forecast to 2029

In Vitro Diagnostics (IVD) Quality Controls: Global Market

In Vitro Diagnostic - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)